Company

Somite Therapeutics, Inc.

Somite Therapeutics uses AI to develop human tissue for cell replacement therapies.

About

Founded in 2023 and based in Boston, Somite Therapeutics develops human tissue for cell therapies using AI models and digital twins of embryonic development. Its AlphaStem platform targets diseases including diabetes, obesity, and muscular dystrophies. Co-founded by Micha Breakstone, Allon Klein, and Cliff Tabin, it raised USD 47.5 million in May 2025 in a Series A led by Khosla Ventures, with participation from SciFi VC, Chan Zuckerberg Initiative, Fusion Fund, Ajinomoto, Pitango HealthTech, TechAviv, and Harpoon Ventures, among others.

3Funding rounds

13Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in